7B3K

Dynamic complex between all-D-enantiomeric peptide D3 with L723P mutant of amyloid precursor protein (APP) 672-726 fragment (amyloid beta 1-55)


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 
  • Conformers Submitted: 
  • Selection Criteria: structures with the least restraint violations 

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

The all-d-enantiomeric peptide D3 designed for Alzheimers disease treatment dynamically interacts with membrane-bound amyloid-beta peptide precursor

Bocharov, E.V.Gremer, L.Urban, A.S.Okhrimenko, I.S.Volynsky, P.E.Nadezhdin, K.D.Bocharova, O.V.Kornilov, D.A.Zagryadskaya, Y.A.Kamynina, A.V.Kuzmichev, P.K.Kutzsche, J.Dencher, N.Arseniev, A.S.Efremov, R.G.Gordeliy, V.I.Willbold, D.Muller-Schiffmann, A.

To be published.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Isoform L-APP677 of Amyloid-beta precursor protein A55Homo sapiensMutation(s): 1 
Gene Names: APPA4AD1
Find proteins for P05067 (Homo sapiens)
Explore P05067 
Go to UniProtKB:  P05067
NIH Common Fund Data Resources
PHAROS:  P05067
Protein Feature View
Expand
  • Reference Sequence
  • Find similar proteins by:  Sequence   |   Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
D3 all D-enantimeric peptide B12synthetic constructMutation(s): 0 
Protein Feature View
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 
  • Conformers Submitted: 
  • Selection Criteria: structures with the least restraint violations 
  • OLDERADO: 7B3K Olderado

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Russian Science FoundationRussian Federation20-64-46027

Revision History  (Full details and data files)

  • Version 1.0: 2021-01-13
    Type: Initial release